Ans van den Ouweland

3.6k total citations
20 papers, 1.4k citations indexed

About

Ans van den Ouweland is a scholar working on Physiology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Ans van den Ouweland has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 7 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Ans van den Ouweland's work include Tuberous Sclerosis Complex Research (15 papers), Histiocytic Disorders and Treatments (7 papers) and Polyomavirus and related diseases (6 papers). Ans van den Ouweland is often cited by papers focused on Tuberous Sclerosis Complex Research (15 papers), Histiocytic Disorders and Treatments (7 papers) and Polyomavirus and related diseases (6 papers). Ans van den Ouweland collaborates with scholars based in Netherlands, United States and United Kingdom. Ans van den Ouweland's co-authors include Dicky Halley, Mark Nellist, Bernard A. Zonnenberg, Anneke Maat‐Kievit, Senno Verhoef, Miriam Goedbloed, Őzgür Sancak, Carine Wouters, Peter Elfferich and Marianne Hoogeveen‐Westerveld and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Neurology.

In The Last Decade

Ans van den Ouweland

20 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ans van den Ouweland Netherlands 18 855 387 315 305 203 20 1.4k
Leena Peltonen Finland 8 155 0.2× 76 0.2× 311 1.0× 295 1.0× 124 0.6× 9 935
Roberto T. Zori United States 18 188 0.2× 62 0.2× 818 2.6× 851 2.8× 65 0.3× 37 1.5k
Jérôme Carayol France 16 127 0.1× 87 0.2× 222 0.7× 300 1.0× 26 0.1× 26 733
David Kronn United States 15 195 0.2× 30 0.1× 270 0.9× 362 1.2× 79 0.4× 35 1.0k
Elżbieta Ciara Poland 17 103 0.1× 67 0.2× 278 0.9× 647 2.1× 49 0.2× 88 1.1k
Ester Lara Spain 12 266 0.3× 151 0.4× 168 0.5× 803 2.6× 25 0.1× 15 1.3k
Eugènia Mato Spain 17 108 0.1× 175 0.5× 107 0.3× 322 1.1× 47 0.2× 34 883
Susan L. Hasegawa United States 13 289 0.3× 79 0.2× 60 0.2× 333 1.1× 167 0.8× 23 832
Jozef Madžo United States 20 141 0.2× 213 0.6× 174 0.6× 1.0k 3.4× 48 0.2× 52 1.5k
Christine K. Ratajczak United States 14 94 0.1× 209 0.5× 94 0.3× 271 0.9× 141 0.7× 41 875

Countries citing papers authored by Ans van den Ouweland

Since Specialization
Citations

This map shows the geographic impact of Ans van den Ouweland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ans van den Ouweland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ans van den Ouweland more than expected).

Fields of papers citing papers by Ans van den Ouweland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ans van den Ouweland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ans van den Ouweland. The network helps show where Ans van den Ouweland may publish in the future.

Co-authorship network of co-authors of Ans van den Ouweland

This figure shows the co-authorship network connecting the top 25 collaborators of Ans van den Ouweland. A scholar is included among the top collaborators of Ans van den Ouweland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ans van den Ouweland. Ans van den Ouweland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nellist, Mark, Rutger W. W. Brouwer, Christel Kockx, et al.. (2015). Targeted Next Generation Sequencing reveals previously unidentified TSC1 and TSC2 mutations. BMC Medical Genetics. 16(1). 10–10. 58 indexed citations
2.
Hoogeveen‐Westerveld, Marianne, Akio Nakashima, Anneke Maat‐Kievit, et al.. (2014). Identification of Regions Critical for the Integrity of the TSC1-TSC2-TBC1D7 Complex. PLoS ONE. 9(4). e93940–e93940. 29 indexed citations
3.
Hoogeveen‐Westerveld, Marianne, Rosemary Ekong, Sue Povey, et al.. (2013). Functional Assessment ofTSC2Variants Identified in Individuals with Tuberous Sclerosis Complex. Human Mutation. 34(2). 409–410. 42 indexed citations
4.
Kantaputra, Piranit Nik, Ans van den Ouweland, Tumtip Sangruchi, & Chanin Limwongse. (2012). Severe plexiform facial neurofibromatosis, type 1 with underdeveloped eyes and a novel NF1 mutation. American Journal of Medical Genetics Part A. 158A(7). 1750–1753. 2 indexed citations
5.
Hoogeveen‐Westerveld, Marianne, Leontine van Unen, Ans van den Ouweland, et al.. (2012). The TSC1-TSC2 complex consists of multiple TSC1 and TSC2 subunits. BMC Biochemistry. 13(1). 18–18. 19 indexed citations
6.
Hoogeveen‐Westerveld, Marianne, Rosemary Ekong, Sue Povey, et al.. (2011). Functional assessment of TSC1 missense variants identified in individuals with tuberous sclerosis complex. Human Mutation. 33(3). 476–479. 34 indexed citations
7.
Wentink, Marjolein, Mark Nellist, Marianne Hoogeveen‐Westerveld, et al.. (2011). Functional characterization of the TSC2 c.3598C>T (p.R1200W) missense mutation that co‐segregates with tuberous sclerosis complex in mildly affected kindreds. Clinical Genetics. 81(5). 453–461. 24 indexed citations
8.
Hoogeveen‐Westerveld, Marianne, et al.. (2010). Analysis of TSC1 truncations defines regions involved in TSC1 stability, aggregation and interaction. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(9). 774–781. 21 indexed citations
9.
Hoogeveen‐Westerveld, Marianne, David J. Kwiatkowski, Julian R. Sampson, et al.. (2009). Identification of a region required for TSC1 stability by functional analysis of TSC1missense mutations found in individuals with tuberous sclerosis complex. BMC Medical Genetics. 10(1). 88–88. 28 indexed citations
10.
Hoogeveen‐Westerveld, Marianne, et al.. (2008). A reliable cell-based assay for testing unclassified TSC2 gene variants. European Journal of Human Genetics. 17(3). 301–310. 23 indexed citations
11.
Nellist, Mark, Diana van den Heuvel, Miriam Goedbloed, et al.. (2008). Missense mutations to the TSC1 gene cause tuberous sclerosis complex. European Journal of Human Genetics. 17(3). 319–328. 21 indexed citations
12.
Jansen, Floor E., Olga Braams, Koen L. Vincken, et al.. (2007). Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations. Neurology. 70(12). 908–915. 73 indexed citations
13.
Jansen, Floor E., Koen L. Vincken, Ale Algra, et al.. (2007). Cognitive impairment in tuberous sclerosis complex is a multifactorial condition. Neurology. 70(12). 916–923. 155 indexed citations
14.
Sancak, Őzgür, Mark Nellist, Miriam Goedbloed, et al.. (2005). Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype – phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex. European Journal of Human Genetics. 13(6). 731–741. 344 indexed citations
15.
Slegtenhorst, Marjon van, Senno Verhoef, Qi Wang, et al.. (1999). Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation. Journal of Medical Genetics. 36(4). 285–289. 105 indexed citations
16.
Jansen, Hans, Adrie J.M. Verhoeven, John J.P. Kastelein, et al.. (1997). Common C-to-T Substitution at Position −480 of the Hepatic Lipase Promoter Associated With a Lowered Lipase Activity in Coronary Artery Disease Patients. Arteriosclerosis Thrombosis and Vascular Biology. 17(11). 2837–2842. 143 indexed citations
17.
Willemsen, Rob, Serieta Mohkamsing, Bert de Vries, et al.. (1997). Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique. Human Genetics. 99(3). 308–311. 81 indexed citations
18.
Gan, K. H., Henk J. Veeze, Ans van den Ouweland, et al.. (1995). A Cystic Fibrosis Mutation Associated with Mild Lung Disease. New England Journal of Medicine. 333(2). 95–99. 123 indexed citations
19.
Janssen, Bart, Mark Nellist, Caroline Hermans, et al.. (1995). Cosmid Contigs from theTuberous Sclerosis CandidateRegion on Chromosome 9q34. European Journal of Human Genetics. 3(2). 78–86. 8 indexed citations
20.
Berns, Anton, et al.. (1985). Presence of markers for virulence in the unique short region or repeat region or both of pseudorabies hybrid viruses. Journal of Virology. 53(1). 89–93. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026